2094 Randomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type metastatic colorectal cancer: HGCSG1001 (Japanese Skin Toxicity Evaluation Protocol With Panitumumab: J-STEPP): Updated analysis of anti-tumor efficacy
| Autor: | Hiraku Fukushima, Yasushi Tsuji, Kazuteru Hatanaka, T. Tagaki, Satoshi Yuki, H. Hisai, M. Tateyama, Yuh Sakata, Masatoshi Kudo, K. Sawada, Yoshito Komatsu, R. Abe, T. Miyagishima, Ichiro Iwanaga, Yoshimitsu Kobayashi, Hiroyuki Okuda, Yasuyuki Kawamoto, Masahiko Koike, Masato Nakamura, N. Ehira |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Antitumor activity
Oncology Cancer Research medicine.medical_specialty Colorectal cancer business.industry Wild type medicine.disease medicine.disease_cause law.invention Skin toxicity Randomized controlled trial law Internal medicine medicine Panitumumab KRAS business Third line treatment medicine.drug |
| Zdroj: | European Journal of Cancer. 51:S359 |
| ISSN: | 0959-8049 |
| DOI: | 10.1016/s0959-8049(16)31016-4 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect